|
Gaza's medical system is on the brink of collapse as Israeli airstrikes have decimated hospitals and the remaining clinics operate without power and supplies. The ongoing violence, combined with pre-existing shortages of medical supplies and fuel, poses a severe threat to the healthcare of Gaza's residents, particularly children who account for a significant portion of pediatric war injuries worldwide.
|
Kaiser Permanente and labor unions have reached a tentative deal following a strike involving over 75,000 union members. The strike, driven by issues including better pay and benefits and addressing staffing shortages, resulted in a four-year agreement, with significant wage increases, enhanced employee benefits, and increased investments in training and development, aimed at resolving these concerns.
|
The American College of Emergency Physicians (ACEP) has disavowed the term "excited delirium," stating that its 2009 white paper on excited delirium syndrome is outdated and not based on recent scientific evidence. This move by ACEP removes excited delirium as a medical diagnosis, and the term will no longer be recognized in court cases, where it had been controversially used to explain deaths in police custody .
|
The European Medicines Agency's safety committee (PRAC) has confirmed that atrial fibrillation will be listed as a common side effect for medicinal products containing omega-3-acid ethyl esters due to a dose-dependent risk increase, requiring permanent discontinuation if atrial fibrillation occurs. These medications are used to treat hypertriglyceridemia, a risk factor for coronary heart disease when lifestyle changes are insufficient.
|
Raynaud's phenomenon, which causes cold and numbness in fingers and toes, is likely influenced by two specific genes, according to a large genetic study published in Nature Communications. These findings could lead to more effective treatments for the condition, which affects 2-5% of the population. Existing medications for Raynaud's can have unwanted side effects, but understanding the genetic basis of the condition may lead to the development of targeted drugs.
|
|